Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Compass Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 40K | Mar 8, 2024 | Direct | ||
Immunome Inc. | Director | Stock option (right to buy) | 11.3K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMNM | Immunome Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
CMPX | Compass Therapeutics, Inc. | Mar 8, 2024 | 1 | $0 | 4 | Mar 11, 2024 | Director |
IMNM | Immunome Inc. | Oct 27, 2023 | 1 | $0 | 4 | Oct 31, 2023 | Director |
IMNM | Immunome Inc. | Oct 2, 2023 | 0 | $0 | 3 | Oct 12, 2023 | Director |
CMPX | Compass Therapeutics, Inc. | Nov 4, 2022 | 0 | $0 | 3 | Nov 10, 2022 | Director |